William Blair & Company’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

William Blair & Company’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-106,237	Closed	-$12.2M	–	1618
2015 Q2	$12.2M	Buy	106,237 +26,375	+33%	+$2.77M	0.02%	822
2015 Q1	$7.63M	Buy	79,862 +1,624	+2%	+$121K	0.01%	911
2014 Q4	$5.26M	Buy	78,238 +404	+0.5%	+$25K	0.01%	1040
2014 Q3	$4.2M	Buy	77,834 +445	+0.6%	+$21.9K	0.01%	1063
2014 Q2	$3.44M	Buy	+77,389	New	+$3.16M	0.01%	1101

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company's CBPO Position: Q3 2015 in Review

William Blair & Company sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2015, closing a stake of 106,237 shares — an estimated $12.2M sold.

William Blair & Company first reported a position in CBPO in Q2 2014 and held it in 5 quarters. The position peaked at $12.2M in Q2 2015. 106 funds tracked by Wall St. Rank hold CBPO as of Q3 2015.

William Blair & Company reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
William Blair & Company sold 106,237 China Biologic Products Holdings, Inc. shares in Q3 2015, an estimated $12.2M.
William Blair & Company first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 5 quarters.
William Blair & Company's China Biologic Products Holdings, Inc. position peaked at $12.2M in Q2 2015.
106 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2015.

Based on William Blair & Company's 13F filing for Q3 2015, filed 12 Nov 2015.